• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制和血脂与移植心脏冠状动脉疾病发生的关系。

Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart.

作者信息

Barbir M, Banner N, Thompson G R, Khaghani A, Mitchell A, Yacoub M

机构信息

Harefield Hospital, London, U.K.

出版信息

Int J Cardiol. 1991 Jul;32(1):51-6. doi: 10.1016/0167-5273(91)90043-o.

DOI:10.1016/0167-5273(91)90043-o
PMID:1864670
Abstract

Coronary arterial disease in the cardiac allograft has emerged as the most serious long term complication of cardiac transplantation. The influence of patient-related and other potential risk factors on the development of coronary arterial disease at 1 year subsequent to cardiac transplantation was examined in 207 recipients. The mean age of donors in patients with coronary arterial disease was 28.5 +/- 9.5 years, compared to 22.6 +/- 7.9 years in patients without coronary arterial disease (P less than 0.01). Eight of the 35 patients who received immunosuppression by means of prednisone and azathioprine developed coronary arterial disease compared to 5 of the 172 patients who were treated with cyclosporin and azathioprine without routine oral prednisone (P less than 0.01). The relationship of levels of serum lipids to the subsequent development of coronary arterial disease was investigated in 95 patients with angiographically normal coronary arteries one year after cardiac transplantation. The cumulative probability of coronary arterial disease in those with total cholesterol greater than 5.8 mmol/l was 9.3% at 2 years (n = 40), 24.4% at 4 years (n = 21) and 45% at 4 years (n = 9) compared with 4.3% at 2 years (n = 45), 7.4% at 3 years (n = 32) and 14% at 4 years (n = 14) in those with a total cholesterol less than 5.8 mmol/l (P less than 0.05). Similarly, the incidence of coronary arterial disease was increased in patients with serum triglyceride greater than 1.4 mmol/l (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

心脏移植中冠状动脉疾病已成为心脏移植最严重的长期并发症。在207名接受者中研究了与患者相关及其他潜在风险因素对心脏移植后1年冠状动脉疾病发生的影响。患冠状动脉疾病患者的供体平均年龄为28.5±9.5岁,而无冠状动脉疾病患者的供体平均年龄为22.6±7.9岁(P<0.01)。35名接受泼尼松和硫唑嘌呤免疫抑制的患者中有8人发生冠状动脉疾病,相比之下,172名接受环孢素和硫唑嘌呤治疗且未常规口服泼尼松的患者中有5人发生冠状动脉疾病(P<0.01)。在95名心脏移植1年后冠状动脉造影正常的患者中研究了血脂水平与随后冠状动脉疾病发生的关系。总胆固醇大于5.8 mmol/l者发生冠状动脉疾病的累积概率在2年时为9.3%(n = 40),4年时为24.4%(n = 21),4年时为45%(n = 9),而总胆固醇小于5.8 mmol/l者在2年时为4.3%(n = 45),3年时为7.4%(n = 32),4年时为14%(n = 14)(P<0.05)。同样,血清甘油三酯大于1.4 mmol/l的患者冠状动脉疾病发病率增加(P<0.05)。(摘要截短于250字)

相似文献

1
Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart.免疫抑制和血脂与移植心脏冠状动脉疾病发生的关系。
Int J Cardiol. 1991 Jul;32(1):51-6. doi: 10.1016/0167-5273(91)90043-o.
2
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients.心脏移植受者中皮质类固醇暴露与血浆脂质水平之间的关系。
Am J Med. 1988 Nov;85(5):632-8. doi: 10.1016/s0002-9343(88)80234-1.
3
Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
Transpl Int. 1991 Sep;4(3):130-5.
4
Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
Circulation. 1990 Nov;82(5 Suppl):IV276-80.
5
Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantation.
Am J Cardiol. 1990 Nov 1;66(15):1135-8. doi: 10.1016/0002-9149(90)90518-6.
6
Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation.低剂量辛伐他汀用于心脏移植受者高胆固醇血症的治疗
Int J Cardiol. 1991 Nov;33(2):241-6. doi: 10.1016/0167-5273(91)90353-q.
7
Factors influencing the development of hypercholesterolemia after cardiac transplantation.
Am J Cardiol. 1992 Aug 15;70(4):520-6. doi: 10.1016/0002-9149(92)91201-e.
8
Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.心脏移植幸存者中加速性冠状动脉疾病的患病率。环孢素与硫唑嘌呤治疗方案的比较。
Circulation. 1989 Nov;80(5 Pt 2):III100-5.
9
High lipid levels and coronary disease in women in Göteborg--outcome and secular trends: a prospective 19 year follow-up in the BEDA*study.哥德堡女性的高血脂水平与冠心病——结局及长期趋势:BEDA*研究的一项为期19年的前瞻性随访
Eur Heart J. 2003 Apr;24(8):704-16. doi: 10.1016/s0195-668x(02)00811-4.
10
Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.服用环孢素A的心脏移植患者中普伐他汀的药代动力学
Int J Clin Pharmacol Ther. 2002 Oct;40(10):439-50. doi: 10.5414/cpp40439.

引用本文的文献

1
Management of hyperlipidaemia associated with heart transplantation.心脏移植相关高脂血症的管理
Drugs. 2004;64(10):1053-68. doi: 10.2165/00003495-200464100-00003.
2
Accelerated graft atherosclerosis after heart transplantation.心脏移植后加速性移植血管动脉粥样硬化
Br Heart J. 1993 May;69(5):469-70. doi: 10.1136/hrt.69.5.469-a.
3
The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures.
心脏移植后移植冠状动脉疾病的发展与心内膜心肌活检来源的T细胞培养物中CD8 + T淋巴细胞占优势相关。
Clin Exp Immunol. 1994 Oct;98(1):158-62. doi: 10.1111/j.1365-2249.1994.tb06623.x.